Cordero Jackson, BSN RN | |
624 Dr Martin Luther King Jr Blvd Apt 9, Newark, NJ 07102-1254 | |
(917) 657-8363 | |
Not Available |
Full Name | Cordero Jackson |
---|---|
Gender | Male |
Speciality | Registered Nurse - School |
Location | 624 Dr Martin Luther King Jr Blvd Apt 9, Newark, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528576899 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WS0200X | Registered Nurse - School | 723035 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Cordero Jackson, BSN RN 624 Dr Martin Luther King Jr Blvd Apt 9, Newark, NJ 07102-1254 Ph: (917) 657-8363 | Cordero Jackson, BSN RN 624 Dr Martin Luther King Jr Blvd Apt 9, Newark, NJ 07102-1254 Ph: (917) 657-8363 |
News Archive
A study led by a researcher at the University of California, San Diego School of Medicine indicates that parent-only treatments for childhood obesity work equally as well as plans that include parents and child, while at the same time more cost effective and potentially easier for families. The results were published today in the advanced online edition of the journal Obesity.
KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today a successful Type B meeting with the Food and Drug Administration (FDA) for its lead pain candidate, KP201.
Yoga has long been promoted as a method for improving physical and mental well-being. And although yoga is often suggested to asthma sufferers to help alleviate symptoms, a new study found little evidence that yoga will improve symptoms.
OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, today announced enrollment of the first patient into the Phase II Investigator Sponsored Trial led by the University of California, San Francisco to assess the anti-tumor activity, safety, and tolerability of the combination of OncoSec's investigational therapy, ImmunoPulse IL-12, and Merck's approved anti-PD-1 agent, KEYTRUDA (pembrolizumab), in patients with unresectable metastatic melanoma.
The Arkansas state insurance commissioner said the efforts to create a state-run exchange were abandoned because of legislative opposition. Meanwhile, in Minnesota, several exchange prototypes will be available online for public review.
› Verified 2 days ago
Mrs. Ariane Monique Chua Dequina, MSN, RN, NP-C, CMSRN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 340 Airis Drive, Newark, NJ 07114 Phone: 973-877-0991 | |
Dr. Nancy S Redeker, PH.D., R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 65 Bergen St Rm 1122, Umdnj School Of Nursing, Newark, NJ 07107 Phone: 973-972-3875 Fax: 973-972-7853 | |
Paul V Scott, CRNA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 111 Central Ave, Newark, NJ 07102 Phone: 973-877-5043 | |
Miriam Salami, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 687 S 17th St, Fl 1, Newark, NJ 07103 Phone: 973-444-5487 | |
Ms. Jessica Hampson, RN, RNFA, CNOR Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 201 Lyons Ave, Newark, NJ 07112 Phone: 973-926-7000 | |
Vasley St.juste, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 75 Sandford Pl, Newark, NJ 07106 Phone: 973-288-3474 | |
Mr. Eduardo Jamisola Padilla Jr., RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 515 Mount Prospect Ave Apt 17b, Newark, NJ 07104 Phone: 201-724-5582 |